Among them, PLXNB1, GRAMD3, and GJA were correlated with Braak NFT stages of AD, suggesting that these genes may be involved in AD pathogenesis and have a high potential for AD biomarker. This evidence concerns the gene GRAMD2B and Alzheimer disease.